Results 161 to 170 of about 10,468 (295)

The Effect of Integrated Lifestyle Intervention Incorporating Calorie‐Carbohydrate Restriction With or Without Time‐Restricted Feeding for Remission of Type 2 Diabetes (DIREM): A Single Blind Randomised Controlled Trial

Endocrinology, Diabetes &Metabolism, Volume 9, Issue 3, May 2026.
Diabetes remission is possible through weight loss. Behavioural lifestyle program is effective to achieve diabetes remission. ABSTRACT Aims We conducted the diet and diabetes remission (DIREM) study to assess whether an integrated lifestyle intervention would lead to achieving remission in type 2 diabetes.
Negin Badrooj, Alireza Esteghamati, Kurosh Djafarian, Mir Saeed Yekaninejad, Saba Mohammadpour, Vida Dankoob, Sahar Karimpour Reyhan, Mahsa Abbaszade, Sara Emamgholipour, Sakineh Shab‐Bidar   +9 more
wiley   +1 more source

ArcDFI: Attention regularization guided by CYP450 interactions for predicting drug-food interactions. [PDF]

PLoS Comput Biol
Gim M, Kang J, Park D, Jeon M.
europepmc   +1 more source

A Multicentre, Prospective, Non‐Interventional Single‐Arm Study Investigating the Impact of Once‐Daily Oral Semaglutide in a Real‐World Adult Population With Type 2 Diabetes in Mexico

Endocrinology, Diabetes &Metabolism, Volume 9, Issue 3, May 2026.
Initiation of oral semaglutide in patients with T2D in routine clinical practice in Mexico significantly reduces HbA1c and weight and improves satisfaction with treatment. ABSTRACT Background To investigate the oral semaglutide use among Mexican adults with type 2 diabetes.
Guillermo González‐Gálvez, Juan C. Garnica‐Cuellar, Miguel Ángel Colín‐García, Aldo Ferreira‐Hermosillo, Silvia A. Jiménez‐Ramos, Aleida Y. Contreras‐Sandoval, Patricia Cruz‐Puente, Manuel Duarte‐Vega   +7 more
wiley   +1 more source

Controllable Ion-Repulsion Enables Rapid and Trace-Level Detection of Hydrophobic Sulfonylurea Herbicides with ICPMS/MS without the Organic Mode. [PDF]

Anal Chem
Lajin B, Goessler W.
europepmc   +1 more source

Hypolipidemic and Hypoglycemic Activity of Goat Milk–Derived Peptides

Food Frontiers, Volume 7, Issue 3, May 2026.
Goat milk–derived bioactive peptides IASAEPTVH, LSTSEENSKK, and TEDELQDK exerted favorable hypolipidemic and hypoglycemic properties. ABSTRACT The prevalence of diabetes and hyperlipidemia worldwide has increased in recent decades. This study aimed to investigate the potential hypoglycemic and hypolipidemic effects of bioactive peptides derived from ...
Rui Wang, Yun Yang, Xinhua Ouyang, Rong He, Xingyun Wang, Xiaoqing Chen   +5 more
wiley   +1 more source

Combined In Vitro and Computational Investigations on Synthesized Sulfonamide-Based Antidiabetic Agents. [PDF]

Pharmaceuticals (Basel)
Iacob AD, Cioancă O, Aprodu I, Tatia R, Iacob AT, Mircea C, Tutunaru D, Pavel AB, Lungu II, Dragostin OM.   +9 more
europepmc   +1 more source

Pharmacological Evaluation of Methanolic Fruit Extract of Lannea coromandelica: Antioxidant, Cytotoxic, Antidiabetic, Antibacterial, Anti‐Inflammatory, and Sedative Activities

Food Science &Nutrition, Volume 14, Issue 5, May 2026.
Phytochemical investigation of Lannea coromandelica through GC–MS and in silico analysis revealed diverse bioactive compounds with promising pharmacological potential. Integrated in vitro and in vivo assays demonstrated significant antioxidant, antidiabetic, antibacterial, anti‐inflammatory, and sedative activities, supporting its therapeutic relevance.
Priota Islam Meem, Zobayed Islam, Nazmul Hasan Eshaque, Md. Jahirul Islam Mamun, Khurram Murad Mojidee, Mohammad Badrudduja, Amit Kumar Dam, S. M. Moazzem Hossen   +7 more
wiley   +1 more source

MCV/Q, Medical College of Virginia Quarterly, Vol. 13 No. 1 [PDF]

, 1977

core   +1 more source

Disentangling treatment status from disease severity in studies of diabetes and Alzheimer's disease biomarkers

Alzheimer's &Dementia, Volume 22, Issue 5, May 2026.
Qifei Fu, Xuan Yin, Shifen Xu
wiley   +1 more source

Registration of high‐yielding conventional soybean ‘R18‐14502’ with broad adaptability in the U.S. Mid‐South

Journal of Plant Registrations, Volume 20, Issue 2, May/August 2026.
Abstract ‘R18‐14502’ (Reg. no. CV‐566, PI 706684) is a conventional maturity group Late‐IV (Relative maturity 4.8) soybean [Glycine max (L.) Merr.] variety developed and released by the University of Arkansas System—Division of Agriculture Research & Extension Center in 2023.
C. Canella Vieira, R. G. Marmo, A. L. Tischler, L. Florez‐Palacios, C. Wu, A. Acuña, D. Harrison, D. Rogers, J. F. Carlin   +8 more
wiley   +1 more source